Evidence map›Paper›PMID 25896650›Full record

ArticleBlood2015

Lack of the nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization.

Geoff Daniels, Bryan A Ballif, Virginie Helias, Carole Saison, Shane Grimsley, Lucienne Mannessier, Hein Hustinx, Edmond Lee, Jean-Pierre Cartron, Thierry Peyrard and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 55 citations in OpenAlex.

  1. Nucleic Acids as Emerging Regulators of Calcium Phosphate Biomineralization.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. How Cryo-EM Has Expanded Our Understanding of Membrane Transporters.Drug metabolism and disposition: the biological fate of chemicals · 2023
    Review
  6. Review
  7. Article
  8. Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (International journal of molecular sciences · 2022
    Review
  9. Glycoproteomic and Phenotypic Elucidation ofInternational journal of molecular sciences · 2022
    Article
  10. Augustine Blood Group System and Equilibrative Nucleoside Transporter 1.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Geoff DanielsInternational Blood Group Reference Laboratory, National Health Service Blood and Transplant, Bristol, United Kingdom;
Bryan A BallifDepartment of Biology, University of Vermont, Burlington, VT;
Virginie HeliasInstitut National de la Transfusion Sanguine, Paris, France;
Carole SaisonInstitut National de la Transfusion Sanguine, Paris, France;
Shane GrimsleyInternational Blood Group Reference Laboratory, National Health Service Blood and Transplant, Bristol, United Kingdom;
Lucienne MannessierCentre Régional de Transfusion Sanguine de Lille, Lille, France;
Hein HustinxBlood Transfusion Service, Swiss Red Cross, Berne, Switzerland;
Edmond LeeRed Cell Immunohaematology Laboratory of Colindale, London, United Kingdom; and.
Jean-Pierre CartronInstitut National de la Transfusion Sanguine, Paris, France;
Thierry PeyrardInstitut National de la Transfusion Sanguine, Département Centre National de Référence pour les Groupes Sanguins, Paris, France.
Lionel ArnaudInstitut National de la Transfusion Sanguine, Paris, France;
Institut National de la Transfusion Sanguine · FRNational Health Service · GBSwiss Red Cross · CHUniversity of Vermont · US

Funding

Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI CHRISTOPHER S FRANCKLYN · 2012 to 2026
$58.4M
NIGMS NIH HHS 8P20GM103449NIGMS NIH HHS P20 GM103449
6 · The paper itself

Abstract

The Augustine-negative alias At(a-) blood type, which seems to be restricted to people of African ancestry, was identified half a century ago but remains one of the last blood types with no known genetic basis. Here we report that a nonsynonymous single nucleotide polymorphism in SLC29A1 (rs45458701) is responsible for the At(a-) blood type. The resulting p.Glu391Lys variation in the last extracellular loop of the equilibrative nucleoside transporter 1 (ENT1; also called SLC29a1) is known not to alter its ability to transport nucleosides and nucleoside analog drugs. Furthermore, we identified 3 individuals of European ancestry who are homozygous for a null mutation in SLC29A1 (c.589+1G>C) and thus have the Augustine-null blood type. These individuals lacking ENT1 exhibit periarticular and ectopic mineralization, which confirms an important role for ENT1/SLC29A1 in human bone homeostasis as recently suggested by the skeletal phenotype of aging Slc29a1(-/-) mice. Our results establish Augustine as a new blood group system and place SLC29A1 as a new candidate gene for idiopathic disorders characterized with ectopic calcification/mineralization.

Indexed as

Polymorphism, Single NucleotideAnimalsBlood Group AntigensEquilibrative Nucleoside Transporter 1FemaleHumansMaleMiceMice, KnockoutOssification, HeterotopicProtein Structure, SecondaryWhite PeopleBlood Group AntigensEquilibrative Nucleoside Transporter 1SLC29A1 protein, humanSLC29A1 protein, mouse

Identifiers

PMID25896650
PMCPMC4458803
OpenAlexW2025822298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.